p16 expression in colorectal adenocarcinoma: Marker of aggressiveness and morphological types

Pathology

Volumn 40, Issue 6, 2008, Pages 580-585

  Lam, Alfred King Yin ^a,c   Ong, Kate ^b   Giv, Mahmound Jafari ^b   Ho, Yik Hong ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Colorectal adenocarcinoma; Expression; p16

Indexed keywords

PROTEIN P16;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER MORPHOLOGY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SURVIVAL; TUMOR DIFFERENTIATION;

EID: 50449094645     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802320713     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Sung JJ, Lau JY, Goh KL, Leung W; Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6: 871-6.
3. Lam AK, Ong K, Ho YH. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 Expression. Dis Colon Rectum 2006; 49: 1275-83.
4. Lam AK, Ho YH. Primary squamous cell carcinoma of the rectum in a patient on immunosuppressive therapy. Pathology 2006; 38: 74-6.
5. Alvarado MD, Jensen EH, Yeatman TJ. The potential role of gene expression in the management of primary and metastatic colorectal cancer. Cancer Control 2006; 13: 27-31.
6. Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127: 265-75.
7. Yuen PW, Man M, Lam KY, Kwong YL. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002; 55: 58-60.
8. Lam AK, Lo CY, Leung P, Lang BH, Chan WF, Luk JM. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma. Ann Surg Oncol 2007; 14: 1772-9.
9. McCluggage WG. Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology 2007; 39: 97-111.
10. Palmqvist R, Rutegard JN, Bozoky B, Landberg G, Stenling R. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol 2000; 157: 1947-53.
11. McKay JA, Douglas JJ, Ross VG, et al. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol 2002; 196: 386-93.
12. Norrie MW, Hawkins NJ, Todd AV, Meagher AP, O'Connor TW, Ward RL. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer. J Surg Oncol 2003; 84: 143-50.
13. Schneider-Stock R, Boltze C, Peters B, et al. Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas. Int J Oncol 2003; 23: 1009-13.
14. Tada T, Watanabe T, Kazama S, et al. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers. Hepatogastroenterology 2003; 50: 1756-60.
15. Cui X, Shirai Y, Wakai T, Yokoyama N, Hirano S, Hatakeyama K. Aberrant expression of pRb and p16(INK4), alone or in combination, indicates poor outcome after resection in patients with colorectal carcinoma. Hum Pathol 2004; 35: 1189-95.
16. Carneiro FP, Ramalho LN, Britto-Garcia S, Ribeiro-Silva A, Zucoloto S. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas. Dis Colon Rectum 2006; 49: 588-94.
17. Zhao P, Mao X, Talbot IC. Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence. World J Gastroenterol 2006; 12: 6391-6.
18. Zhao P, Hu YC, Talbot IC. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol 2003; 9: 2202-6.
19. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, editors. WHO Classification of Tumours: Pathology and Genetics of Tumours of Digestive System. Lyon: IARC Press, 2000; 105-119.
20. th ed. Berlin: Springer-Verlag, 2002.
21. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-8.
22. Kapiteijn E, Liefers GJ, Los LC, et al. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001; 195: 171-8.
23. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005; 54: 374-84.
24. Lam KY, Law S, Lo T, Tung HM, Wong J. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients. Am J Gastroenterol 1999; 94: 2060-8.
25. Lam KY, Chan ACL, Chan KW, Leung ML, Srivastava G. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur J Surg Oncol 1995; 21: 613-6.
26. Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid: A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 2000; 231: 329-38.